1. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414–423
2. Nelson DR, Koymans L, Kamataki T et al (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6:1–42
3. Kinirons MT, Crome P (1997) Clinical pharmacokinetic considerations in the elderly. an update. Clin Pharmacokinet 33:302–312
4. Jusko WJ (1978) Role of tobacco smoking in pharmacokinetics. J Pharmacokinet Biopharm 6:7–39
5. Hamilton M, Wolf JL, Rusk J, Beard SE, Clark GM, Witt K, Cagnoni PJ (2006) Effects of smoking on the pharmacokinetics of erlotinib. Clin Cancer Res 12(7 Pt 1):2166–2171